ZEROCHol 10 Tablet contains Rosuvastatin 10 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and enhancing clearance of LDL particles from the bloodstream. This mechanism contributes to the prevention of atherosclerosis and reduces the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with established coronary heart disease or those at high risk. ZEROCHol 10 is indicated as an adjunct to diet and lifestyle modifications including exercise, weight control, and smoking cessation. The recommended dosage is individualized based on patient response and lipid profile, with regular monitoring of liver function tests and creatine kinase advised to detect potential adverse effects. Common side effects include headache, myalgia, and gastrointestinal disturbances, while serious adverse reactions such as rhabdomyolysis are rare but require immediate medical attention. Use of ZEROCHol 10 should be under strict medical supervision, especially in patients with hepatic impairment or concomitant use of interacting drugs.